Clinical Trial Update: Conventional Androgen Deprivation Therapy (ADT) With or Without Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating conventional androgen deprivation therapy with or without Abiraterone acetate plus prednisone and apalutamide in prostate cancer pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)
• Apalutamide (apalutamide)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Prostate Cancer | Phase 3 | Status: TERMINATED | Results posted: 2024-09-19